MedTrace Logo

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

NCT04577248 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-10-08

No results posted yet for this study

Summary

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Conditions

  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Tricuspid Valve Regurgitation

Interventions

DEVICE

edge-to-edge valve repair

edge-to-edge valve repair

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Patrick Mayr, MD · Dept. of Anesthesiology, Deutsches Herzzentrum München

  • Michael Joner, Prof · Dept. of Cardiology, Deutsches Herzzentrum München

  • Tobias Rheude, MD · Dept. of Cardiology, Deutsches Herzzentrum München

  • Costanza Pellegrini, MD · Dept. of Cardiology, Deutsches Herzzentrum München

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2030-12-31
Completion
2031-01-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04577248 on ClinicalTrials.gov